March 23rd, 2013
María Dolores Cospedal, president of the Autonomous Community of Castile la Mancha, visits Chemo 23 March 2013
The president of Castilla-La Mancha, Mrs. Maria Dolores de Cospedal, along with other regional authorities and the Mayor of Azuqueca de Henares, D. Bellido Paul visited Liconsa plant.
January 8th, 2013
The certificate has been issued by the certifier SGS, after successfully audit that guarantees the good practices and the correct implementation of the environmental management system in the manufacturing plant of the Group located in the municipality of Azuqueca de Henares, in Guadalajara.
December 27th, 2012
This partnership intends to provide a strong impetus to the actions that help prevent and treat Chagas. The declaration was subscribed by DNDi and Carlos Slim Health Institute, among others.
December 18th, 2012
The Territorial delegate of the Board of Castilla y León, Mr. Guillermo García, and the Territorial Director of the D.T. of ADE Investments and Services of Leon, Mr. José Manuel Frade, visited Leon Farma facility.
December 12th, 2012
With 20,000 square meters area and an investment up to the date of $80 million, this state-of-the-art drug drug product facility does the fill & finish of mAbxience´s monoclonal antibodies.
December 11th, 2012
CHEMO today announced that it has completed the acquisition of 75% of PT Nufarindo. This transaction will give a platform to grow in Indonesia and to bring its own patented products into the local market.
October 8th, 2012
CHEMO participates in edition number twenty-two of the international exhibition CPhI Worldwide, which is held in Madrid, from 9 to 11 October at IFEMA (Hall 4: General and Intermediates, booth 4D31).
September 8th, 2012
Measuring and managing CHEMO`s environmental footprint becomes a part of our corporate strategy and is one of our commitments to achieve sustainable development.
June 1st, 2012
CHEMO reinforces market possition in Latin America and Eticos, based in Paraguay, becomes a strategic asset for the industrial business.
April 14th, 2012
mAbxience is committed to improving healthcare and living conditions, increasing the availability of biopharmaceuticals worldwide.